Physician profile
Tina S Ipe
NPI 1972746048
$41,759.84
in general payments reported to CMS, 2019-2025
9 companies · $2,513 in 2025
The $2,513 reported for 2025 was more than what 78% of Clinical Pathology/Laboratory Medicine providers received nationally (typical 2025 total: $114).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,857 · 2020: $280 · 2021: $13K · 2022: $8,913 · 2023: $4,626 · 2024: $7,400 · 2025: $2,513.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $7,400 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $6,400 · Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $7,400.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $6,400.00 |
| Food and Beverage | $739.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Bct, INC. | $20,316.99 | 2019-2025 | Spectra Optia, Spectra Optia, Trima Accel |
| Alexion Pharmaceuticals, INC. | $18,806.36 | 2019-2025 | Ultomiris |
| Cerus Corporation | $2,076.09 | 2019 | |
| Octapharma USA, INC. | $168.73 | 2023 | Fibryga, Balfaxar |
| Genzyme Corporation | $149.46 | 2022-2023 | |
| Galderma Laboratories, L.P. | $89.39 | 2025 | |
| Fresenius Kabi USA, LLC | $72.49 | 2023 | Alyx Component Collection System |
| Ortho-Clinical Diagnostics, INC. | $56.22 | 2019 | |
| Abbott Laboratories | $24.11 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tina Ipe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.